Cargando…
Disruption of multiple copies of the Prostaglandin F2alpha synthase gene affects oxidative stress response and infectivity in Trypanosoma cruzi
Chagas disease, caused by the protozoan Trypanosoma cruzi, is a serious chronic parasitic disease, currently treated with Nifurtimox (NFX) and Benznidazole (BZ). In addition to high toxicity, these drugs have low healing efficacy, especially in the chronic phase of the disease. The existence of drug...
Autores principales: | Santi, Ana Maria Murta, Ribeiro, Juliana Martins, Reis-Cunha, João Luís, Burle-Caldas, Gabriela de Assis, Santos, Isabella Fernandes Martins, Silva, Paula Alves, Resende, Daniela de Melo, Bartholomeu, Daniella Castanheira, Teixeira, Santuza Maria Ribeiro, Murta, Silvane Maria Fonseca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581433/ https://www.ncbi.nlm.nih.gov/pubmed/36260546 http://dx.doi.org/10.1371/journal.pntd.0010845 |
Ejemplares similares
-
Genomics and functional genomics in Leishmania and Trypanosoma cruzi: statuses, challenges and perspectives
por: Bartholomeu, Daniella C, et al.
Publicado: (2021) -
Trypanosoma cruzi iron superoxide dismutases: insights from phylogenetics to chemotherapeutic target assessment
por: Hickson, Jéssica, et al.
Publicado: (2022) -
The MASP Family of Trypanosoma cruzi: Changes in Gene Expression and Antigenic Profile during the Acute Phase of Experimental Infection
por: dos Santos, Sara Lopes, et al.
Publicado: (2012) -
In vitro activity of 1,3-bisaryloxypropanamines against
Trypanosoma cruzi-infected L929 cultures
por: Lavorato, Stefânia Neiva, et al.
Publicado: (2015) -
The gene repertoire of the main cysteine protease of Trypanosoma cruzi, cruzipain, reveals four sub-types with distinct active sites
por: Santos, Viviane Corrêa, et al.
Publicado: (2021)